Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Download references

Open Access Open Badges

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

Yun Choi, Ho Won Lee, Jaetae Lee and Yong Hyun Jeon*

BMC Cancer 2013, 13:143  doi:10.1186/1471-2407-13-143